Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T12706 |
Reslizumab
Sch 55700 |
IL Receptor | Immunology/Inflammation |
Reslizumab is humanized monoclonal antibodies that target interleukin-5 (IL-5) for the treatment of eosinophilic asthma. |